Hot Topics: BTSPosted on: 19 Dec 2018
Steve Holmes, Somerset GP, and Carol Stonham, Primary Care Respiratory Nurse, preview the 2019 BTS/SIGN asthma update.
No dramatic changes are expected, with the emphasis being on assessing current symptoms and reducing risk of exacerbation. A previous history of asthma will remain the strongest predictor of exacerbation. This is followed by poor control/excessive use of SABA, and second-hand smoking (for children).
Supported by a 2018 literature review, house dust mite eradication will now feature in a multiple intervention process. There will be no changes from earlier BTS/SIGN guidance regarding either the use of FeNO testing or LTRA.